Retia Medical aims to provide accurate cardiovascular information and insights to help clinicians improve outcomes for high-risk patients. Retia brings together industry-leading expertise in physiology, signal processing, data science, and computational algorithms to engineer innovative hemodynamic monitoring solutions that give clinicians accurate, real-time data that they can rely on to make patient care decisions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/18/22 | $15,000,000 | Series B |
Fresenius Medical Care Ventures Pritzker/Vlock Family Office Red Cedar Ventures | undisclosed |
